AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
10 124
GBX
-6.33%
Market Cap:
157B
GBX
Balance Sheet
Balance Sheet Decomposition
AstraZeneca PLC
AstraZeneca PLC
| Current Assets | 25.8B |
| Cash & Short-Term Investments | 5.7B |
| Receivables | 14.8B |
| Other Current Assets | 5.3B |
| Non-Current Assets | 78.2B |
| Long-Term Investments | 1.9B |
| PP&E | 11.6B |
| Intangibles | 58.2B |
| Other Non-Current Assets | 6.5B |
Balance Sheet
AstraZeneca PLC
AstraZeneca PLC
Currency: USD
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
6 240
|
5 018
|
3 324
|
4 831
|
5 369
|
7 832
|
6 329
|
6 166
|
5 840
|
5 488
|
|
| Cash |
1 250
|
782
|
784
|
893
|
755
|
1 182
|
1 461
|
1 411
|
1 325
|
1 215
|
|
| Cash Equivalents |
4 990
|
4 236
|
2 540
|
3 938
|
4 614
|
6 650
|
4 868
|
4 755
|
4 515
|
4 273
|
|
| Short-Term Investments |
613
|
884
|
1 230
|
849
|
849
|
160
|
69
|
239
|
122
|
166
|
|
| Total Receivables |
5 591
|
4 001
|
4 275
|
4 345
|
5 181
|
5 651
|
8 795
|
9 923
|
11 935
|
13 094
|
|
| Accounts Receivables |
4 633
|
2 583
|
2 802
|
2 995
|
3 813
|
3 956
|
6 324
|
7 508
|
8 859
|
9 631
|
|
| Other Receivables |
958
|
1 418
|
1 473
|
1 350
|
1 368
|
1 695
|
2 471
|
2 415
|
3 076
|
3 463
|
|
| Inventory |
2 143
|
2 334
|
3 035
|
2 890
|
3 193
|
4 024
|
8 983
|
4 699
|
5 424
|
5 288
|
|
| Other Current Assets |
1 420
|
1 025
|
1 286
|
2 676
|
971
|
1 877
|
2 068
|
1 566
|
1 733
|
1 791
|
|
| Total Current Assets |
16 007
|
13 262
|
13 150
|
15 591
|
15 563
|
19 544
|
26 244
|
22 593
|
25 054
|
25 827
|
|
| PP&E Net |
6 413
|
6 848
|
7 615
|
7 421
|
8 335
|
8 917
|
10 171
|
9 449
|
10 502
|
11 647
|
|
| PP&E Gross |
6 413
|
6 848
|
7 615
|
7 421
|
8 335
|
8 917
|
10 171
|
9 449
|
10 502
|
11 647
|
|
| Accumulated Depreciation |
7 435
|
6 603
|
7 024
|
7 218
|
7 517
|
8 193
|
8 324
|
7 743
|
8 599
|
8 875
|
|
| Intangible Assets |
22 646
|
27 586
|
26 188
|
21 959
|
20 833
|
20 947
|
42 387
|
39 307
|
38 089
|
37 177
|
|
| Goodwill |
11 800
|
11 658
|
11 825
|
11 707
|
11 668
|
11 845
|
19 997
|
19 820
|
20 048
|
21 025
|
|
| Note Receivable |
907
|
901
|
847
|
515
|
348
|
325
|
504
|
592
|
529
|
574
|
|
| Long-Term Investments |
543
|
826
|
1 036
|
922
|
1 459
|
1 147
|
1 237
|
1 142
|
1 677
|
1 900
|
|
| Other Long-Term Assets |
1 740
|
1 445
|
2 693
|
2 536
|
3 171
|
4 004
|
4 823
|
3 580
|
5 220
|
5 885
|
|
| Other Assets |
11 800
|
11 658
|
11 825
|
11 707
|
11 668
|
11 845
|
19 997
|
19 820
|
20 048
|
21 025
|
|
| Total Assets |
60 056
N/A
|
62 526
+4%
|
63 354
+1%
|
60 651
-4%
|
61 377
+1%
|
66 729
+9%
|
105 363
+58%
|
96 483
-8%
|
101 119
+5%
|
104 035
+3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 469
|
2 990
|
3 611
|
1 720
|
1 774
|
2 350
|
2 824
|
2 550
|
3 267
|
3 640
|
|
| Accrued Liabilities |
3 190
|
3 095
|
3 794
|
5 148
|
5 085
|
4 994
|
8 079
|
8 303
|
8 861
|
8 283
|
|
| Short-Term Debt |
189
|
94
|
152
|
160
|
154
|
370
|
387
|
350
|
515
|
330
|
|
| Current Portion of Long-Term Debt |
727
|
2 213
|
2 095
|
1 594
|
1 856
|
2 016
|
1 506
|
5 192
|
4 885
|
2 346
|
|
| Other Current Liabilities |
7 294
|
6 864
|
6 731
|
7 670
|
9 248
|
10 577
|
9 798
|
9 898
|
13 014
|
13 267
|
|
| Total Current Liabilities |
14 869
|
15 256
|
16 383
|
16 292
|
18 117
|
20 307
|
22 594
|
26 293
|
30 542
|
27 866
|
|
| Long-Term Debt |
14 137
|
14 501
|
15 560
|
17 359
|
16 217
|
17 994
|
28 888
|
23 690
|
23 222
|
27 619
|
|
| Deferred Income Tax |
2 665
|
3 956
|
3 995
|
3 286
|
2 490
|
2 918
|
6 206
|
2 944
|
2 844
|
3 305
|
|
| Minority Interest |
19
|
1 815
|
1 682
|
1 576
|
1 469
|
16
|
19
|
21
|
23
|
85
|
|
| Other Liabilities |
9 876
|
12 144
|
10 774
|
9 670
|
9 957
|
9 872
|
8 388
|
6 498
|
5 345
|
4 374
|
|
| Total Liabilities |
41 566
N/A
|
47 672
+15%
|
48 394
+2%
|
48 183
0%
|
48 250
+0%
|
51 107
+6%
|
66 095
+29%
|
59 446
-10%
|
61 976
+4%
|
63 249
+2%
|
|
| Equity | |||||||||||
| Common Stock |
316
|
316
|
317
|
317
|
328
|
328
|
387
|
387
|
388
|
388
|
|
| Retained Earnings |
13 870
|
10 187
|
10 250
|
7 724
|
4 858
|
7 323
|
3 755
|
1 495
|
3 567
|
5 172
|
|
| Additional Paid In Capital |
4 304
|
4 351
|
4 393
|
4 427
|
7 941
|
7 971
|
35 126
|
35 155
|
35 188
|
35 226
|
|
| Total Equity |
18 490
N/A
|
14 854
-20%
|
14 960
+1%
|
12 468
-17%
|
13 127
+5%
|
15 622
+19%
|
39 268
+151%
|
37 037
-6%
|
39 143
+6%
|
40 786
+4%
|
|
| Total Liabilities & Equity |
60 056
N/A
|
62 526
+4%
|
63 354
+1%
|
60 651
-4%
|
61 377
+1%
|
66 729
+9%
|
105 363
+58%
|
96 483
-8%
|
101 119
+5%
|
104 035
+3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 264
|
1 265
|
1 266
|
1 267
|
1 312
|
1 313
|
1 549
|
1 550
|
1 550
|
1 551
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
